Anti-Human HLA-DR Purified

Grouped product items
Size Price Qty
25 ug
$110.00
100 ug
$200.00

Additional LN3 Formats

Cat.No. Format Starting From
74111-50 FITC $ 170.00
74111-70 PerCP-Cyanine5.5 $ 475.00
74111-80 APC $ 195.00
74111-60 PE $ 145.00
74111-20 Purified $ 110.00
Catalog Number : 74111-20

description

The LN3 monoclonal antibody specifically reacts with the human leukocyte antigen-DR (HLA-DR), a MHC class II heterodimeric surface glycoprotein. HLA-DR is expressed on the antigen presenting surfaces of monocytes, macrophages, dendritic cells, activated T cells, and B cells. It is integral to peptide presentation to CD4+ T cells.

Additional Information

Clone:
LN3
Format:
Purified
Applications:
FC
Reactivity:
Human
Isotype:
Mouse IgG2b, kappa
Research Interest: Adaptive Immunity
Cell Type: B Cells, Macrophage / Monocyte, T Cells
Application: FC
Clone: LN3
Preparation:
The product should be stored undiluted at 4°C. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography.
Formulation:
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
References:

Norton, A. J., & Isaacson, P. G. (1987). Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. The American journal of pathology128(2), 225.

Hua, Z. X., Tanaka, K. E., Tazelaar, H. D., Myers, J., Markowitz, G. S., & Borczuk, A. C. (1998). Immunoreactivity for LN2 and LN3 distinguishes small cell carcinomas from non-small cell carcinomas in the lung. Human pathology,29(12), 1441-1446.

Ioachim, H. L., Pambuccian, S. E., Hekimgil, M., Giancotti, F. R., & Dorsett, B. H. (1996). Lymphoid monoclonal antibodies reactive with lung tumors: diagnostic application. The American journal of surgical pathology20(1), 64-71.

© BioGems International, Inc. All rights reserved.